Adagio Medical Holdings, Inc. (ADGM)
NASDAQ: ADGM · Real-Time Price · USD
0.8604
-0.0404 (-4.48%)
At close: May 15, 2026, 4:00 PM EDT
0.8689
+0.0085 (0.99%)
After-hours: May 15, 2026, 4:10 PM EDT
Adagio Medical Holdings Employees
Adagio Medical Holdings had 80 employees as of December 31, 2024. The number of employees decreased by 5 or -5.88% compared to the previous year.
Employees
80
Change
-5
Growth
-5.88%
Revenue / Employee
n/a
Profits / Employee
-$304,575
Market Cap
19.11M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 80 | -5 | -5.88% |
| Jun 30, 2024 | 87 | - | - |
| Dec 31, 2023 | 85 | -12 | -12.37% |
| Dec 31, 2022 | 97 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Accuray | 990 |
| Myomo | 195 |
| Cytosorbents | 129 |
| IRIDEX | 93 |
| Lifeward | 81 |
| VolitionRx | 75 |
| Picard Medical | 75 |
| Pulsenmore | 71 |
ADGM News
- 4 days ago - Adagio Medical Reports First Quarter 2026 Results and Meaningful Clinical Progress - Business Wire
- 17 days ago - Adagio Medical to Participate in the BofA Securities 2026 Health Care Conference - Business Wire
- 20 days ago - Adagio Medical reports six-month results from Fulcrum-VT IDE trial - TheFly
- 20 days ago - Adagio Medical Announces Positive Pivotal Results for vCLAS® Ventricular Ablation System - Business Wire
- 4 weeks ago - Adagio Medical's ULTA Technology to Be Featured at the Heart Rhythm 2026 Conference - Business Wire
- 4 weeks ago - Adagio Medical initiated with an Overweight at Piper Sandler - TheFly
- 5 weeks ago - Adagio Medical announces FDA granted IDE approval for FULCRUM-VT trial - TheFly
- 5 weeks ago - Adagio Medical Receives IDE Approval from the FDA to Investigate Next-Generation vCLAS® Ventricular Ablation System - Business Wire